Protagonist Therapeutics Inc, created in 2000 (United States), from 2214 competing brands. Protagonist Therapeutics Inc is owned by Protagonist Therapeutics Inc, listed on the stock exchange of New York Protagonist Therapeutics Inc belongs to the Biotechnology business sector.

Protagonist Therapeutics Inc is a brand of Protagonist Therapeutics Inc (PTGX) Share price

Share price and profitability of the share Protagonist Therapeutics Inc (Protagonist Therapeutics Inc)

Buy Protagonist Therapeutics Inc share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 24.75

Portfolio valuation
Protagonist Therapeutics Inc over 5 years* USD 59.24

Stock market history Protagonist Therapeutics Inc

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more